Ibisobanuro
Hagati ya tofacitinib izwi kandi nka cis-1-benzyl-4-methyl-3-methylaminopiperidine dihydrochloride kandi ifite CAS numero 1062580-52-2.Hagati ni ikintu cy'ingenzi mu gukora tofacitinib, imiti ikoreshwa mu kuvura rubagimpande ya rubagimpande, arthrite ya psoriatic na colitis ulcerative.Nkumuhuza wingenzi muri synthesis ya tofacitinib, ibicuruzwa byacu nibyingenzi kubashakashatsi ba farumasi nababikora.
Uru ruganda ruciriritse rwahujwe neza kugirango urwego rwohejuru rwubuziranenge no guhuzagurika.Hamwe nuburyo bugezweho bwo gukora inganda ningamba zikomeye zo kugenzura ubuziranenge, urashobora kwizera ko abahuza bacu ba tofacitinib bujuje amahame yo mu rwego rwo hejuru agenga isuku n’umutekano.
Hagati ya Tofacitinib (3R, 4R) -1-Benzyl-3- (Mmethylamino) -4-Mmethylpiperidine DiHClide ifite uburyo bwinshi bwo kuyikoresha, ikagira umutungo w'agaciro mu bushakashatsi bwa farumasi na chimique.Waba ukora ubushakashatsi bwamasomo cyangwa guteza imbere imiti, ibice byacu bigereranya bitanga ibisubizo byizewe kandi bihendutse kubyo ukeneye byihariye.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ry'umwuga ryizeza R&D y'ibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
